Biomarker Services
Tissue Biomarker Profiling
Integrated tissue biomarker profiling designed to turn complex tissue samples into reliable, decision-ready insights for clinical trials and translational research.
From Tissue to Biomarker Insight
<p>AcelaBio brings tissue preparation, biomarker detection, digital imaging, pathology expertise, and quantitative analysis together within an integrated workflow. From standard histology through multiplexed and molecular techniques, each program is developed around the scientific objective and intended use of the biomarker.</p>
Biomarker Solutions
Complex Biomarker Programs Require More Than a Single Assay
<p>Biomarker programs can involve multiple technologies, complex tissue requirements, specialized interpretation, and demanding clinical-trial timelines. Fragmenting that work across multiple providers can introduce additional hand-offs, variability, and delays. AcelaBio’s integrated approach is designed to connect these stages within a coordinated pathology workflow.</p>
An Integrated Approach Built Around Your Program
<p>Rather than starting with a fixed menu of tests, AcelaBio works from the scientific objective of the program. Tissue handling, assay selection and development, imaging, pathology review, and downstream analysis can be brought together into a workflow designed around the biomarker’s intended use.</p>
From initial sample handling through analysis and interpretation, each stage is connected to help maintain consistency, quality, and scientific context throughout the program.
Sample Receipt & Preparation
Accessioning, tissue processing, embedding and sectioning establish a controlled foundation for downstream biomarker analysis.
Biomarker Profiling
Histology, IHC, multiplexed immunofluorescence, in situ hybridization and other appropriate methods are applied according to the objectives of the program.
Imaging & Quantitative Analysis
Whole-slide imaging and digital image analysis transform tissue-based signals into reproducible quantitative data.
Pathology Review & Insight
Pathologist oversight, biomarker scoring and structured analysis bring the results together into interpretable, decision-ready outputs.